Today: 7 February 2026
Subscribe
Browse Category

Insider Trading News 31 December 2025

Home Depot stock today: HD slips into the year-end close as investors eye Fed signals and an insider sale filing

Home Depot stock today: HD slips into the year-end close as investors eye Fed signals and an insider sale filing

NEW YORK, December 31, 2025, 15:50 ET — Regular session Home Depot shares were down about 0.3% at $345.33 in late-afternoon New York trading on Wednesday, underperforming earlier highs as the broader market eased into the final session of 2025. The stock traded between $344.87 and $346.69; rival Lowe’s was down about 0.5% and the SPDR S&P 500 ETF fell about 0.5%. The muted move still matters for a rate-sensitive corner of retail. Home-improvement spending tends to follow housing turnover and financing conditions, and investors are positioning for how quickly borrowing costs ease in early 2026. Fresh U.S. data on
31 December 2025
·····
Oklo stock slips today after SEC filings show insiders moved 15 million OKLO shares into trusts

Oklo stock slips today after SEC filings show insiders moved 15 million OKLO shares into trusts

NEW YORK, December 31, 2025, 3:29 PM ET — Regular session Oklo Inc. shares slipped on Wednesday after regulatory filings showed the nuclear startup’s top executives shifted large blocks of stock into family and estate-planning trusts. The disclosures matter because Oklo’s shares have been volatile, and trading has often been sensitive to insider activity and potential dilution at early-stage companies that are still working toward commercial deployment. They also land as investors reassess the pace of U.S. nuclear buildout and the long approval timelines that can make or break project schedules for advanced reactor developers. Oklo shares were down about
31 December 2025
····
Ford stock today: F slips in thin year-end session as traders eye insider filing and Feb. 10 earnings

Ford stock today: F slips in thin year-end session as traders eye insider filing and Feb. 10 earnings

NEW YORK, December 31, 2025, 03:14 PM ET — Regular session Ford Motor (NYSE: F) shares were down about 0.6% at $13.16 in afternoon trading on Wednesday. The stock has ranged from $13.15 to $13.24, with about 16.5 million shares traded. The move matters now because the final session of the year often brings light volumes and portfolio rebalancing, which can exaggerate routine price swings. Thin liquidity — the ease of buying and selling without moving a stock’s price — can sharpen moves in cyclical names like automakers, where sentiment can shift quickly on macro signals and company updates. A
31 December 2025
····
Nebius stock dips as insiders flag share sales in SEC filings

Nebius stock dips as insiders flag share sales in SEC filings

NEW YORK, December 31, 2025, 15:20 ET — Regular session Nebius Group N.V. shares slipped on Wednesday as investors weighed insider notices to sell stock. The Nasdaq-listed shares were down about 1.9% at $83.59 in afternoon trading. The filings hit during year-end trading, when liquidity is typically thin and moves can be exaggerated. Nebius, a Netherlands-based data center operator, has drawn outsized attention as a “neocloud” provider — a firm that rents out high-end computing power for AI — after landing multi-billion-dollar infrastructure contracts with Microsoft and Meta Platforms. Reuters That backdrop makes insider supply a live issue, even when
31 December 2025
·····
Alignment Healthcare stock rises today despite new insider-sale filings, with ALHC near $20

Alignment Healthcare stock rises today despite new insider-sale filings, with ALHC near $20

NEW YORK, December 31, 2025, 14:50 ET — Regular session Alignment Healthcare, Inc. shares rose about 3.4% to $19.90 in mid-afternoon trading on Wednesday, after earlier touching $19.93 as the stock fluctuated between $18.83 and $19.93. The move came as investors weighed a cluster of insider-transaction disclosures that can shape sentiment in smaller healthcare names, especially in thin year-end markets. Liquidity has been patchy heading into the New Year holiday, a setup that can magnify price swings. “Profit-taking opportunities” tend to show up “when liquidity was low,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters A Form 4 filing
31 December 2025
····
CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

CoreWeave stock drops as insider sale filing hits thin year-end trade — what’s next for CRWV

NEW YORK, December 31, 2025, 14:40 ET — Regular session CoreWeave Inc shares were down 3.1% at $71.63 on Wednesday afternoon, after an insider sale disclosure drew attention in thin year-end trading. The stock hit a session low of $71.46. The timing matters because trading conditions are patchy heading into the New Year’s Day holiday, when lower liquidity can amplify moves in single names. For a recently listed company with a volatile tape, incremental supply can weigh on sentiment even without new fundamental news. Investors have also been sensitive to funding and dilution risk in capital-intensive AI infrastructure plays. CoreWeave
31 December 2025
····
AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

AST SpaceMobile (ASTS) stock slips today as insider buy filing, AT&T satellite update keep launch focus

NEW YORK, December 31, 2025, 13:57 ET — Regular session AST SpaceMobile, Inc. (ASTS) shares were down 0.8% at $74.05 in early afternoon trading on Wednesday, after swinging between $72.53 and $75.73. The Nasdaq-tracking Invesco QQQ was off about 0.2%. The pullback matters because AST’s valuation has become tightly linked to a handful of near-term execution checkpoints: satellite launches, ground network buildout and carrier readiness. Those milestones can move the stock even when the broader market is quiet. The company is trying to deliver “direct-to-device” connectivity — linking satellites to standard smartphones without specialized equipment — and investors are watching
31 December 2025
·····
CoreWeave stock slides in year-end trade after insider sale filing puts CRWV back in focus

CoreWeave stock slides in year-end trade after insider sale filing puts CRWV back in focus

NEW YORK, December 31, 2025, 12:57 ET — Regular session CoreWeave (CRWV) shares fell 2.0% to $72.40 by 12:57 p.m. ET, after trading between $72.04 and $74.30 in the session. The move matters because CoreWeave remains a high-volatility play on artificial intelligence infrastructure, where investors have been quick to react to signals about insider selling and capital needs. SEC+1 Year-end positioning is adding another layer, with investors looking to lock in tax losses and rebalance portfolios in a market that can turn jumpy on thin liquidity. Business Insider A Form 4 filed with the U.S. Securities and Exchange Commission showed
31 December 2025
···
Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

Lionsgate Studios stock today: LION slides after insider sale filings hit the tape

NEW YORK, December 31, 2025, 12:52 ET — Regular session Shares of Lionsgate Studios Corp fell 3.4% to $8.94 in midday trading on Wednesday after regulatory filings disclosed stock sales by two top executives. The stock opened at $9.16 and traded between $8.94 and $9.16, with about 1.23 million shares changing hands. The move matters because the studio’s shares have been trading near yearly highs, leaving less cushion for negative headlines. Insider sales are routine, but they can act as a trigger for profit-taking when a stock has rallied and investors are hunting for the next catalyst. The disclosures also
31 December 2025
······
Rocket Lab stock today: RKLB steadies near $70 as insider filing and ARK trim hit the tape

Rocket Lab stock today: RKLB steadies near $70 as insider filing and ARK trim hit the tape

NEW YORK, December 31, 2025, 12:48 ET — Regular session Rocket Lab Corp shares edged higher on Wednesday after a regulatory filing showed a board member sold stock, as investors wrapped up a volatile year for the space launch and satellite company. The stock was up about 0.2% at $70.61. Google The insider disclosure lands with Rocket Lab among 2025’s standout gainers. Shares have risen about 180% this year, according to Investors Business Daily, making late-year signals on positioning and insider activity more closely watched. Investors.com With year-end trading thinning out, even routine filings can catch attention in high-beta names
31 December 2025
·····
Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

Cogent Biosciences (COGT) stock slips as insider sales follow bezuclastinib FDA filing

NEW YORK, December 31, 2025, 11:55 ET — Regular session Shares of Cogent Biosciences slid on Wednesday, paring losses from earlier in the session, after the biotech disclosed a key regulatory filing while investors digested a cluster of insider stock sales. The stock was down 2.5% at $36.19, after touching a low of $34.33. The move comes as Cogent shifts from late-stage data to the U.S. Food and Drug Administration review process — a step that can widen the audience beyond biotech specialists and pull more short-term traders into the name. A New Drug Application, or NDA, is the formal
31 December 2025
·····
GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

NEW YORK, December 31, 2025, 12:13 ET — Regular session Alphabet’s Class C shares (GOOG) edged down 0.04% to $314.43 in midday trading on Wednesday, after an insider-trading filing showed the company’s chief legal officer sold shares. The stock has traded between $312.34 and $315.37 so far in the session. The move comes in thin year-end trading, when lower volumes can exaggerate short-term swings. Alphabet’s stock has been a heavyweight driver of U.S. equity gains in 2025, leaving investors alert to any sign of profit-taking as the calendar turns. Wall Street’s major indexes were slightly lower on the final trading
31 December 2025
···
1 … 13 14 15 16 17 … 28

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop